Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 7 June 2027
- Last conf. stmt
- 24 May 2026
Kandy Therapeutics Limited
- Incorporated
- 3 May 2017 (9 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Owned by
- Bayer Consumer Care AG
- Accounts type
- Full
- Region
- South East
- Address
- 400 South Oak WayReadingRG2 6AD
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 18 February 2025
Israeli
Born October 1970 (56)
Director · Appointed 18 October 2024
British
Born August 1965 (61)
Barker, Colin Andrew
Secretary · Appointed 8 September 2020
Officer history (12 former)
14 March 2025
18 February 2025
31 December 2024
18 October 2024
22 September 2021
22 September 2021
25 August 2021
Resigned Kurdikar, Sreeparna Arun as Director
25 August 2021
9 September 2020
Resigned Richardson, Josh, Dr as Director
8 September 2020
8 September 2020
Appointed Kurdikar, Sreeparna Arun as Director
8 September 2020
Appointed Barker, Colin Andrew as Secretary
8 September 2020
Resigned Kay, Andrew Martin as Director
8 September 2020
Resigned Prosser, Ena, Dr as Director
8 September 2020
Resigned Dukes, Iain David, Dr as Director
8 September 2020
8 September 2020
8 September 2020
Resigned Mulder, Geert Jan, Dr as Director
24 August 2018
Appointed Richardson, Josh, Dr as Director
6 June 2018
Appointed Kay, Andrew Martin as Director
14 September 2017
14 September 2017
Appointed Mulder, Geert Jan, Dr as Director
14 September 2017
14 September 2017
Appointed Prosser, Ena, Dr as Director
14 September 2017
Appointed Dukes, Iain David, Dr as Director
14 September 2017
Resigned Trower, Michael Keith, Dr as Director
3 May 2017
Appointed Trower, Michael Keith, Dr as Director
Ownership 2 active
People and entities with significant control, from the Companies House PSC register
Bayer Consumer Care AG
Corporate entity · Notified 6 October 2026
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. Che-107.359.454
Bayer AG
Corporate entity · Notified 6 October 2026
Has significant influence or control
Listed Public Company Limited By Shares
Reg. no. Hrb 48248
Former controllers (3)
6 October 2026
Ceased Bayer Global Investments BV — Owns 75–100% of shares
24 August 2018
Ceased Advent Life Sciences LLP — Owns 25–50% of shares
14 September 2017
Ceased Michael Keith Trower — Owns 75–100% of shares
Filings 94
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 28 October 2026 | Cessation of a person with significant control | |||
| 28 October 2026 | Notification of a person with significant control | |||
| 28 October 2026 | Notification of a person with significant control | |||
| 28 October 2026 | Change of details for a person with significant control | |||
| 2 July 2026 | Full accounts | 31 December 2025 |
Some other companies at this address
Other companies in this industry
Newcastle Upon Tyne
Edinburgh
Edinburgh
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →